Description
Peptide Composition
KLOW 80 mg is composed of the following peptide blend:
BPC-157 – 10 mg
TB-500 (Thymosin Beta-4 fragment) – 10 mg
GHK-Cu (Copper Peptide) – 50 mg
KPV (Lys-Pro-Val) – 10 mg
This multi-compound formulation allows for the investigation of multiple biological pathways within a single experimental model.
Biochemical Characteristics
Each peptide in the KLOW complex is synthesized using advanced solid-phase peptide synthesis (SPPS) techniques and purified through high-performance liquid chromatography (HPLC), with analytical verification via mass spectrometry.
Form: Lyophilized powder
Total Content: 80 mg per vial
Purity: ≥ 99% (analytical standard)
Manufacturing: Controlled laboratory environment
The use of high-purity peptide compounds is critical for reducing variability and ensuring reproducibility in controlled research settings.
Research Context
Peptides included in the KLOW formulation are commonly studied for their involvement in:
Cellular signaling and communication pathways
Tissue-related and extracellular matrix interactions
Peptide-receptor binding dynamics
Inflammatory and regulatory pathway modeling
In-vitro and preclinical experimental systems
The combined formulation allows researchers to explore synergistic or complementary interactions between peptide sequences within controlled environments.
Form & Stability
KLOW is supplied in lyophilized form to maintain structural integrity and stability during storage and transport. Lyophilization removes moisture under controlled conditions, preserving peptide structure.
Storage guidelines:
Store in a cool, dry place
Protect from light
Refrigeration recommended after reconstitution
Disclaimer
This product is intended for laboratory research purposes only.
Not for human consumption, medical, diagnostic, or therapeutic use.
All information provided is for scientific and educational purposes only.






Reviews
There are no reviews yet.